CRON — Cronos Group Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
$3.38
+$0.01 (+0.30%)
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Michael Ryan Gorenstein J.D., based in 4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0, with about 459 employees. Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
Latest reported CRON revenue for 2025-09-30 was $36.3M. Net income was $28.3M. Revenue was up 8.6% from 2025-06-30 to 2025-09-30. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
Use this CRON page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRON quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRON SEC filings page. Lician reads the product cache first so this HTML stays unique to Cronos Group Inc even when a live quote feed is slow.
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
CRON Key Statistics
Market Cap
$738.28M
Volume
2.17M
Previous Close
$3.31
Day Range
$3.27 – $3.45
P/E Ratio
13.64
EPS
$0.11
Revenue
$117.61M
Net Income
$40.02M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+34.8%
Profit Margin
34.0%
Employees
459
CRON Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $117.61M | $87.24M | $86.75M | $64.56M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $40.02M | -$74.55M | -$168.73M | -$397.20M |
| EPS (Diluted) | $0.11 | -$0.19 | -$0.45 | -$1.07 |
Total Assets
$1.17B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$858.80M
Operating Cash Flow
$18.84M
Free Cash Flow
$0.00
Cronos Group Inc Company Information
- President, CEO & Chairman
- Michael Ryan Gorenstein J.D.
- Headquarters
- 4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0
- Website
- thecronosgroup.com
- Phone
- 416-504-0004
- IPO / Founded
- 2016-07-12
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic